Khella

OTHER NAME(S): Ammi, Ammi Visnage, Bischofskrautfruchte, Bishop's Weed, Bishop's Weed Fruit, Fenouil Annuel, Fruits de Khella, Herbe aux Cure-Dents, Herbe aux Gencives, Khellin, Khelline, Noukha, Toothpick Ammi, Toothpick Plant, Visnaga, Visnaga Fruit, Visnagae, Visnagafruchte, Visnagin, Ammi visnaga, Ammi daucoides, Daucus visnaga, Bishops Weed, Bishop's Weed Fruit, Khella Fruit, Visnaga Fruit, Biznaga

Overview

Khella is a plant. The dried, ripe fruit is used to make medicine. People commonly prepare an "extract" by removing khellin, one of the active chemicals in khella, and dissolving it in a liquid that is then used as medicine. Khella is less commonly prepared as a tea.

People use khella for conditions such as asthma and other lung problems, diseases of the heart and blood vessels, diabetes, menstrual pain, and many others, but there is no good scientific evidence to support these uses.

Be careful not to confuse khella with its less commonly used relative, bishop's weed. The two species contain some of the same chemicals and work similarly in the body, but khella is more commonly used for heart and lung conditions, and bishop's weed is more commonly used for skin conditions.

Khella contains substances that seem to relax and widen blood vessels; decrease heart contraction; open up the lungs; increase "good cholesterol" (HDL, high-density lipoprotein); and fight bacteria, viruses, and fungi.

Several prescription drugs including amiodarone, nifedipine, and cromolyn have been developed from khella.

Khella contains substances that seem to relax and widen blood vessels; decrease heart contraction; open up the lungs; increase "good cholesterol" (HDL, high-density lipoprotein); and fight bacteria, viruses, and fungi.

Several prescription drugs including amiodarone, nifedipine, and cromolyn have been developed from khella.

References
  1. Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Trans. S. Klein. Boston, MA: American Botanical Council, 1998.
  2. The Review of Natural Products by Facts and Comparisons. St. Louis, MO: Wolters Kluwer Co., 1999.
  3. Wichtl MW. Herbal Drugs and Phytopharmaceuticals. Ed. N.M. Bisset. Stuttgart: Medpharm GmbH Scientific Publishers, 1994.
  4. Martindale W. Martindale the Extra Pharmacopoeia. Pharmaceutical Press, 1999.
  5. Brinker F. Herb Contraindications and Drug Interactions. 2nd ed. Sandy, OR: Eclectic Medical Publications, 1998.
  6. Osher HL, Katz KH, Wagner DJ. Khellin in the treatment of angina pectoris. N Engl J Med 1951;244:315-21.
  7. Tritrungtasna O, Jerasutus S, Suvanprakorn P. Treatment of alopecia areata with khellin and UVA. Int J Dermatol 1993;32:690.
  8. Abdel-Fattah A, Aboul-Enein MN, Wassel GM, El-Menshawi BS. An approach to the treatment of vitiligo by khellin. Dermatologica 1982;165:136-40.
  9. Duarte J, Torres AI, Zarzuelo A. Cardiovascular effects of visnagin on rats. Planta Med 2000;66:35-9.
  10. Hudsin J, Towers GHN. Phytomedicines as antivirals. Drugs Fut 1999;24:295-320.
  11. Abdel-Fattah A, Aboul-Enein MN, Wassel G, El-Menshawi B. Preliminary report on the therapeutic effect of khellin in psoriasis. Dermatologica 1983;167:109-10.
  12. Ossenkoppele PM, van der Sluis WG, van Vloten WA. [Phototoxic dermatitis following the use of Ammi majus fruit for vitiligo]. Ned Tijdschr Geneeskd 1991;135:478-80.
  13. Harvengt C, Desager JP. HDL-cholesterol increase in normolipaemic subjects on khellin: a pilot study. Int J Clin Pharmacol Res 1983;3:363-6.
  14. Durate J, Vallejo I, Perez-Vizcaino F, et al. Effects of visnadine on rat isolated vascular smooth muscles. Planta Med 1997;63:233-6.
  15. Duarte J, Perez-Vizcaino F, Torres AI, et al. Vasodilator effects of visnagin in isolated rat vascular smooth muscle. Eur J Pharmacol 1995;286:115-22.
  16. Rauwald HW, Brehm O, Odenthal KP. The involvement of a Ca2+ channel blocking mode of action in the pharmacology of Ammi visnaga fruits. Planta Med 1994;60:101-5.
  17. Fetrow CW, Avila JR. Professional's Handbook of Complementary & Alternative Medicines. 1st ed. Springhouse, PA: Springhouse Corp., 1999.
  18. Chevallier A. Encyclopedia of Herbal Medicine. 2nd ed. New York, NY: DK Publ, Inc., 2000.
  19. Dr. Duke's Phytochemical and Ethnobotanical Databases. Available at: https://www.ars-grin.gov/duke/.
  20. de Leeuw J, van der BN, Maierhofer G, et al. A case study to evaluate the treatment of vitiligo with khellin encapsulated in L-phenylalanin stabilized phosphatidylcholine liposomes in combination with ultraviolet light therapy. Eur J Dermatol 2003;13(5):474-477.
  21. Orecchia G, Perfetti L. Photochemotherapy with topical khellin and sunlight in vitiligo. Dermatology 1992;184(2):120-123.
  22. Valkova, S., Trashlieva, M., and Christova, P. Treatment of vitiligo with local khellin and UVA: comparison with systemic PUVA. Clin.Exp.Dermatol. 2004;29(2):180-184.
  23. Haug KG, Weber B, Hochhaus G, Butterweck V. Pharmacokinetic evaluation of visnagin and Ammi visnaga aqueous extract after oral administration in rats. Planta Med. 2012;78(17):1831-6.
  24. Rao XL, Liu LL, Huang J, Chen J. Neuroprotective effects of visnagin on cerebral ischemia-reperfusion injury rats and the underlying mechanisms. Eur Rev Med Pharmacol Sci 2022;26(12):4371-4379.
  25. Abukhalil MH, Hussein OE, Aladaileh SH, et al. Visnagin prevents isoproterenol-induced myocardial injury by attenuating oxidative stress and inflammation and upregulating Nrf2 signaling in rats. J Biochem Mol Toxicol 2021;35(11):e22906.
  26. Vanti G, Di Cesare Mannelli L, Micheli L, et al. The Anti-Arthritic Efficacy of Khellin Loaded in Ascorbyl Decanoate Nanovesicles after an Intra-Articular Administration. Pharmaceutics 2021;13(8):1275.